Articles with public access mandates - nicholas HAYWARDLearn more
OverallNHMRCNIHCancer Research UKWellcomeEuropean CommissionARCMRCGovernment of SpainSwedish Research CouncilKWFNIHRDoDGenome CanadaGovernment of ItalyCIHRWorldwide Cancer Research, UKHelmholtzAcademy of FinlandINSERMDFGDFFAIRC Foundation for Cancer Research in ItalyNWOBreast Cancer Now, UKANRBMBFMelanoma Research AllianceSusan G. KomenDOESNSFNASANSFCFORTEEPSRCRCNSCLBusiness Finland
Not available anywhere: 20
Leptin and the risk of Barrett’s oesophagus
BJ Kendall, GA Macdonald, NK Hayward, JB Prins, I Brown, N Walker, ...
Gut 57 (4), 448-454, 2008
Mandates: US National Institutes of Health
A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma
KAW Wadt, LG Aoude, P Johansson, A Solinas, A Pritchard, O Crainic, ...
Clinical genetics 88 (3), 267-272, 2015
Mandates: US National Institutes of Health, National Health and Medical Research …
Melanomas of unknown primary have a mutation profile consistent with cutaneous sun‐exposed melanoma
K Dutton‐Regester, H Kakavand, LG Aoude, MS Stark, MG Gartside, ...
Pigment cell & melanoma research 26 (6), 852-860, 2013
Mandates: National Health and Medical Research Council, Australia
Exome sequencing to predict neoantigens in melanoma
AL Pritchard, JG Burel, MA Neller, NK Hayward, JA Lopez, M Fatho, ...
Cancer immunology research 3 (9), 992-998, 2015
Mandates: National Health and Medical Research Council, Australia
MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis
V Tembe, SJ Schramm, MS Stark, E Patrick, V Jayaswal, YH Tang, ...
Pigment cell & melanoma research 28 (3), 254-266, 2015
Mandates: Australian Research Council, National Health and Medical Research Council …
Prolonged stable disease in a uveal melanoma patient with germline MBD4 nonsense mutation treated with pembrolizumab and ipilimumab
PA Johansson, A Stark, JM Palmer, K Bigby, K Brooks, O Rolfe, ...
Immunogenetics 71, 433-436, 2019
Mandates: National Health and Medical Research Council, Australia
Identification of TFG (TRK‐fused gene) as a putative metastatic melanoma tumor suppressor gene
K Dutton‐Regester, LG Aoude, DJ Nancarrow, MS Stark, L O'Connor, ...
Genes, Chromosomes and Cancer 51 (5), 452-461, 2012
Mandates: US National Institutes of Health
Somatic Hypermutation of the YAP Oncogene in a Human Cutaneous Melanoma
X Zhang, JZ Tang, IA Vergara, Y Zhang, P Szeto, L Yang, C Mintoff, ...
Molecular Cancer Research 17 (7), 1435-1449, 2019
Mandates: National Health and Medical Research Council, Australia
Identification of ARHGEF17, DENND2D, FGFR3, and RB1 mutations in melanoma by inhibition of nonsense‐mediated mRNA decay
S Bloethner, A Mould, M Stark, NK Hayward
Genes, Chromosomes and Cancer 47 (12), 1076-1085, 2008
Mandates: German Research Foundation
Exploration of peptides bound to MHC class I molecules in melanoma
AL Pritchard, ML Hastie, M Neller, JJ Gorman, CW Schmidt, NK Hayward
Pigment cell & melanoma research 28 (3), 281-294, 2015
Mandates: National Health and Medical Research Council, Australia
Mutation load in melanoma is affected by MC1R genotype
PA Johansson, AL Pritchard, AM Patch, JS Wilmott, JV Pearson, ...
Pigment cell & melanoma research 30 (2), 255-258, 2017
Mandates: National Health and Medical Research Council, Australia
Histologic and epidemiologic correlates of P-MAPK, Brn-2, pRb, p53, and p16 immunostaining in cutaneous melanomas
NM Richmond-Sinclair, E Lee, MC Cummings, R Williamson, HK Muller, ...
Melanoma research 18 (5), 336-345, 2008
Mandates: US National Institutes of Health
Prevalence of BRAF and NRAS mutations in fast-growing melanomas.
E Nagore, E Hacker, A Martorell‐Calatayud, V Traves, C Guillen, ...
Pigment cell & melanoma research 26 (3), 2013
Mandates: Australian Research Council, National Health and Medical Research Council …
Germline RAD51B truncating mutation in a family with cutaneous melanoma
KAW Wadt, LG Aoude, L Golmard, TVO Hansen, X Sastre-Garau, ...
Familial cancer 14, 337-340, 2015
Mandates: National Health and Medical Research Council, Australia
Tumor mutation burden and structural chromosomal aberrations are not associated with T-cell density or patient survival in acral, mucosal, and cutaneous melanomas
J Edwards, PM Ferguson, SN Lo, I Pires da Silva, AJ Colebatch, H Lee, ...
Cancer Immunology Research 8 (11), 1346-1353, 2020
Mandates: National Health and Medical Research Council, Australia
FRAMe: Familial Risk Assessment of Melanoma—a risk prediction tool to guide CDKN2A germline mutation testing in Australian familial melanoma
EA Holland, S Lo, B Kelly, H Schmid, AE Cust, JM Palmer, M Drummond, ...
Familial cancer 20 (3), 231-239, 2021
Mandates: US National Institutes of Health, National Health and Medical Research …
Genomic analysis of adult case of ocular surface giant congenital melanocytic nevus and associated clinicopathological findings
LA McGrath, JM Palmer, A Stark, W Glasson, SK Warrier, K Whitehead, ...
Ophthalmic Genetics 41 (6), 616-620, 2020
Mandates: National Health and Medical Research Council, Australia
Immune signatures in cutaneous melanoma correlate with survival independently of immunotherapy treatment
PA Johansson, NK Hayward, AL Pritchard
Pigment Cell & Melanoma Research 36 (2), 246-251, 2023
Mandates: National Health and Medical Research Council, Australia
Melanocyte transformation requires complete loss of all pocket protein function via a mechanism that mitigates the need for MAPK pathway activation
ID Tonks, P Mukhopadhyay, WA Schroder, A Sorolla, AW Mould, ...
Oncogene 36 (26), 3789-3795, 2017
Mandates: National Health and Medical Research Council, Australia
Exploring the Germline Genetics of In Situ and Invasive Cutaneous Melanoma: A Genome-Wide Association Study Meta-Analysis
N Ingold, M Seviiri, JS Ong, RE Neale, N Pandeya, DC Whiteman, ...
JAMA dermatology, 2024
Mandates: National Health and Medical Research Council, Australia
Publication and funding information is determined automatically by a computer program